Novartis Wins Temporary Restraining Order Extension Against Teva Over Generic Lotrel
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva must halt sales of generic versions of the blood pressure medication; generics that have already reached distributors can be sold.
You may also be interested in...
Mylan Launches Generic Norvasc; 180-Day Exclusivity May Be Moot
Pfizer counters by launching an “authorized” generic under its Greenstone brand.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.